• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2017年古巴皮肤利什曼病输入病例:人员流动的作用

Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement.

作者信息

Monzote Lianet, González Daniel, Blanco Orestes, Fraga Jorge, Capó Virginia, Herrera Alberto, Montalvo Ana Margarita

机构信息

Parasitology Department, Instituto de Medicina Tropical Pedro Kourí, Autopista Novia del Mediodía Km 6 1/2, La Habana, Cuba.

Department of Medicine, Instituto de Medicina Tropical Pedro Kourí, Autopista Novia del Mediodía Km 6 1/2, La Habana, Cuba.

出版信息

Trop Dis Travel Med Vaccines. 2022 Jul 1;8(1):15. doi: 10.1186/s40794-022-00171-9.

DOI:10.1186/s40794-022-00171-9
PMID:35773710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9248147/
Abstract

BACKGROUND

Leishmaniasis is a vector-borne disease caused by several species from genus Leishmania. An increase in the number of cases related to human movement has been informed in the last years. Due to the increase of suspicious leishmaniasis cases arriving in Cuba during 2017, a general analysis is presented herein.

METHODS

Clinical samples were collected from 5 patients suspicious of leishmaniasis, received from January to December 2017 at the Institute of Tropical Medicine Pedro Kourí, Cuba. Skin lesion samples were analyzed using different diagnostic assays: direct smear, histological examination, and molecular analysis for species identification. Epidemiological and demographic data were requested from each case and analyzed. Treatment and follow up of patient was also performed.

RESULTS

Five cases were confirmed as Leishmania infection according to microscopic observation and molecular methods results. PCR-18S, PCR-N/RFLP and PCR-F/RFLP identified the following species: L. panamensis (2 cases), L. braziliensis (1 case), L.panamensis/L.guyanensis (1 case), L. mexicana complex (1 case). In treated patients, drugs were well tolerated, cure were documented and no relapse have been currently reported (3 years later).

CONCLUSIONS

Clinical characteristics, demographic data, and epidemiological features of infection for each case evidence the potential risk related with travel to endemic areas of leishmaniasis.

KEYWORKS

Cutaneous leishmaniasis, Epidemiology, Imported cases.

摘要

背景

利什曼病是一种由利什曼原虫属的几种物种引起的媒介传播疾病。近年来,与人类流动相关的病例数量有所增加。由于2017年抵达古巴的疑似利什曼病病例增多,本文进行了综合分析。

方法

从2017年1月至12月在古巴佩德罗·库里热带医学研究所接收的5例疑似利什曼病患者中采集临床样本。对皮肤病变样本采用不同的诊断方法进行分析:直接涂片、组织学检查以及用于物种鉴定的分子分析。收集并分析了每个病例的流行病学和人口统计学数据。同时对患者进行了治疗和随访。

结果

根据显微镜观察和分子方法结果,5例确诊为利什曼原虫感染。PCR-18S、PCR-N/RFLP和PCR-F/RFLP鉴定出以下物种:巴拿马利什曼原虫(2例)、巴西利什曼原虫(1例)、巴拿马利什曼原虫/圭亚那利什曼原虫(1例)、墨西哥利什曼原虫复合体(1例)。在接受治疗的患者中,药物耐受性良好,有治愈记录,目前尚未报告复发情况(3年后)。

结论

每个病例的临床特征、人口统计学数据和感染的流行病学特征证明了前往利什曼病流行地区旅行存在的潜在风险。

关键词

皮肤利什曼病;流行病学;输入性病例

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead0/9248147/ecfd64fc3d76/40794_2022_171_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead0/9248147/ecfd64fc3d76/40794_2022_171_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead0/9248147/ecfd64fc3d76/40794_2022_171_Fig1_HTML.jpg

相似文献

1
Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement.2017年古巴皮肤利什曼病输入病例:人员流动的作用
Trop Dis Travel Med Vaccines. 2022 Jul 1;8(1):15. doi: 10.1186/s40794-022-00171-9.
2
Imported leishmaniasis cases in Cuba (2006-2016): what have we learned.古巴的输入性利什曼病病例(2006 - 2016年):我们学到了什么。
Trop Dis Travel Med Vaccines. 2018 Aug 7;4:7. doi: 10.1186/s40794-018-0067-3. eCollection 2018.
3
Molecular Identification of Parasites Causing Cutaneous Leishmaniasis in Panama.巴拿马皮肤利什曼病寄生虫的分子鉴定。
Am J Trop Med Hyg. 2021 Jan 11;104(4):1326-1334. doi: 10.4269/ajtmh.20-1336.
4
Molecular and histological tools to diagnose an imported case of American cutaneous leishmaniasis in Cuba.用于诊断古巴一例输入性美洲皮肤利什曼病病例的分子和组织学工具。
Int J Dermatol. 2015 Oct;54(10):1175-9. doi: 10.1111/ijd.12915. Epub 2015 Jun 12.
5
Molecular epidemiology of imported cases of leishmaniasis in Australia from 2008 to 2014.2008年至2014年澳大利亚输入性利什曼病病例的分子流行病学
PLoS One. 2015 Mar 3;10(3):e0119212. doi: 10.1371/journal.pone.0119212. eCollection 2015.
6
Molecular typing reveals the co-existence of two transmission cycles of American cutaneous leishmaniasis in the Andean Region of Venezuela with Lutzomyia migonei as the vector.分子分型显示,在委内瑞拉安第斯地区,以米氏白蛉为媒介的美洲皮肤利什曼病存在两个传播周期并存的情况。
Mem Inst Oswaldo Cruz. 2018 Dec 6;113(12):e180323. doi: 10.1590/0074-02760180323.
7
Imported leishmaniasis in travelers: a 7-year retrospective from a Parisian hospital in France.旅行者输入性利什曼病:法国巴黎一家医院的 7 年回顾性研究。
BMC Infect Dis. 2021 Sep 15;21(1):953. doi: 10.1186/s12879-021-06631-5.
8
Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.巴西亚马逊地区由巴西利什曼原虫和圭亚那利什曼原虫引起的粘膜利什曼病。
PLoS Negl Trop Dis. 2011 Mar 8;5(3):e980. doi: 10.1371/journal.pntd.0000980.
9
ITS1 PCR-RFLP Diagnosis and Characterization of Leishmania in Clinical Samples and Strains from Cases of Human Cutaneous Leishmaniasis in States of the Mexican Southeast.墨西哥东南部各州人类皮肤利什曼病病例临床样本及菌株中利什曼原虫的ITS1 PCR-RFLP诊断与鉴定
Interdiscip Perspect Infect Dis. 2014;2014:607287. doi: 10.1155/2014/607287. Epub 2014 Jul 1.
10
Mucosal leishmaniasis: A forgotten disease, description and identification of species in 50 Colombian cases.黏膜利什曼病:一种被遗忘的疾病,50例哥伦比亚病例的物种描述与鉴定
Biomedica. 2019 Aug 1;39(Supl. 2):58-65. doi: 10.7705/biomedica.v39i3.4347.

引用本文的文献

1
Expression and immunogenicity evaluation of a novel Lentiviral multi- epitope vaccine against Leishmania major in BALB/c mice.新型慢病毒多表位疫苗抗硕大利什曼原虫在BALB/c小鼠中的表达及免疫原性评估
Trop Dis Travel Med Vaccines. 2025 Jul 1;11(1):17. doi: 10.1186/s40794-025-00254-3.
2
Constituents of the Stem Bark of Linn. f. with Antileishmanial and Antibacterial Activities.《柳叶蜡梅茎皮的化学成分及其抗利什曼原虫和抗菌活性》
Molecules. 2023 Mar 8;28(6):2473. doi: 10.3390/molecules28062473.

本文引用的文献

1
Distribution, treatment outcome and genetic diversity of Leishmania species in military personnel from Colombia with cutaneous leishmaniasis.哥伦比亚皮肤利什曼病军人中利什曼原虫的分布、治疗结果和遗传多样性。
BMC Infect Dis. 2020 Dec 9;20(1):938. doi: 10.1186/s12879-020-05529-y.
2
Epidemiology, clinical pattern and impact of species-specific molecular diagnosis on management of leishmaniasis in Belgium, 2010-2018: A retrospective study.2010-2018 年比利时利什曼病的流行病学、临床特征和种特异性分子诊断对其管理的影响:一项回顾性研究。
Travel Med Infect Dis. 2020 Nov-Dec;38:101885. doi: 10.1016/j.tmaid.2020.101885. Epub 2020 Sep 22.
3
An interactive database of Leishmania species distribution in the Americas.
美洲利什曼原虫物种分布交互式数据库。
Sci Data. 2020 Apr 3;7(1):110. doi: 10.1038/s41597-020-0451-5.
4
The importance of vector control for the control and elimination of vector-borne diseases.病媒控制对于控制和消除病媒传播疾病的重要性。
PLoS Negl Trop Dis. 2020 Jan 16;14(1):e0007831. doi: 10.1371/journal.pntd.0007831. eCollection 2020 Jan.
5
Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges.纳米材料在利什曼病中的应用:聚焦最新进展与挑战
Nanomaterials (Basel). 2019 Dec 9;9(12):1749. doi: 10.3390/nano9121749.
6
Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform.利什曼原虫属对抗两性霉素 B 和氟康唑的敏感性检测,使用 Sensititre™ YeastOne™ YO9 平台。
BMC Infect Dis. 2019 Jul 8;19(1):593. doi: 10.1186/s12879-019-4237-3.
7
Imported cutaneous leishmaniasis: a 13-year experience of a Polish tertiary center.输入性皮肤利什曼病:波兰一家三级医疗中心的13年经验
Postepy Dermatol Alergol. 2019 Feb;36(1):104-111. doi: 10.5114/ada.2019.82830. Epub 2019 Feb 22.
8
Nonconventional opponents: a review of malaria and leishmaniasis among United States Armed Forces.非传统对手:美国武装部队中的疟疾和利什曼病综述
PeerJ. 2019 Jan 25;7:e6313. doi: 10.7717/peerj.6313. eCollection 2019.
9
Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major.将唑类抗真菌药重新用作抗利什曼原虫药:具有对硕大利什曼原虫有前景的体外抗利什曼原虫活性的新型3-三唑基黄酮。
Parasitol Int. 2019 Apr;69:103-109. doi: 10.1016/j.parint.2018.12.006. Epub 2018 Dec 21.
10
Leishmaniasis.利什曼病。
Lancet. 2018 Sep 15;392(10151):951-970. doi: 10.1016/S0140-6736(18)31204-2. Epub 2018 Aug 17.